Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 400

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 400
---
, 2025, the Company’s Board of Directors granted directors, officers and employees options to purchase up to 20,313shares of common stock for $ 28.60per share. The grants have various vesting conditions, including time-based and performance-based terms. These stock options expire on March 4, 2035. On March 10, 2025, the Company redeemed 316shares of Series C Preferred Stock from certain investors for a cash payment of $ 395,000, or $ 1,250per share of Series C Preferred Stock. F-62 Up to 12,500,000 Shares of Common Stock CERO THERAPEUTICS HOLDINGS, INC. PRELIMINARY PROSPECTUS , 2025 PART II INFORMATION NOT REQUIRED IN PROSPECTUS Item 13. Other Expenses of Issuance and Distribution. The following table sets forth the estimated expenses to be borne by the registrant in connection with the securities being registered hereby.

| Expense                                             |     | Estimated 
 Amount    |           |
|:----------------------------------------------------|:----|:----------|----------:|
| Securities and Exchange Commission registration fee |     | $         | 15,979.82 |
| FINRA filing fee                                    |     |           |         * |
| Accounting fees and expenses                        |     |           |         * |
| Legal fees and expenses                             |     |           |         * |
| Financial printing and miscellaneous expenses       |     |           |         * |
| Total                                               |     | $         |         * |

| * | These fees are calculated based                                                                       
 on the securities offered and the number of issuances and accordingly cannot be defined at this time. |

Item 14. Indemnification of Directors and Officers Section 145(a) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party to or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because he or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such